Amryt Pharma Stock Deutsche Boerse AG

Stocks

Delayed Deutsche Boerse AG Other stock markets			5-day change	1st Jan Change
- ^EUR	-.--%		-.--%	-

21-11-22	Amryt Pharma to Delist from LSE's Main Market in January 2022	MT
21-09-13	Amryt Pharma : Boosts FY21 Revenue Guidance Following Chiasma Purchase	MT

21-11-22	Amryt Pharma to Delist from LSE's Main Market in January 2022	MT
21-09-13	Amryt Pharma : Boosts FY21 Revenue Guidance Following Chiasma Purchase	MT
21-08-06	Amryt Pharma : Hikes FY21 Guidance As H1 Loss Narrows On Strong Growth	MT
21-08-05	Amryt Pharma : Completes Acquisition Of Chiasma	MT
21-07-29	Novacyt : CEO to Retire; Amryt Pharma Exec Named Successor	MT
21-06-28	Amryt Pharma : Sends Invitation To Shareholders To Vote For Chiasma Acquisition	MT
21-06-03	Amryt Pharma : Wins US FDA's Priority Review Status For Rare Genetic Skin Disorder Drug	MT
21-06-02	Amryt Pharma : Receives New Drug Application Status For Oleogel-S10 In US	MT
21-03-31	Amryt Pharma : Submits New Rare Disease Drug for US FDA Approval	MT
21-03-30	Amryt Pharma : Reports Encouraging Results From Familial Chylomicronaemia Syndrome Drug Trial	MT
21-03-29	Amryt Pharma : Shares Rise 5% on European Medicines Agency Progress for Skin Disorder Drug	MT
21-03-23	Amryt Pharma : Seeks to Double Leptin Deficiency Drug Myalepta's Market Share in US	MT
21-03-22	Amryt Pharma : Myalepta Receives Reimbursement Approval in France	MT

Employees

Sector